PRESTIGE CONSUMER HEALTHCARE (PBH) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PBH - US74112D1019 - Common Stock
65.715 USD
-0.08 (-0.13%)
Overall PBH gets a fundamental rating of 6 out of 10. We evaluated PBH against 190 industry peers in the Pharmaceuticals industry. PBH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. PBH has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
- PBH had positive earnings in the past year.
- In the past year PBH had a positive cash flow from operations.
- Of the past 5 years PBH 4 years were profitable.
- In the past 5 years PBH always reported a positive cash flow from operatings.
1.2 Ratios
- PBH has a better Return On Assets (5.83%) than 86.84% of its industry peers.
- PBH's Return On Equity of 11.00% is amongst the best of the industry. PBH outperforms 85.79% of its industry peers.
- PBH's Return On Invested Capital of 7.88% is amongst the best of the industry. PBH outperforms 85.79% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for PBH is below the industry average of 12.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.83% | ||
| ROE | 11% | ||
| ROIC | 7.88% |
ROA(3y)3.39%
ROA(5y)4.11%
ROE(3y)6.22%
ROE(5y)8.76%
ROIC(3y)8.16%
ROIC(5y)7.67%
1.3 Margins
- The Profit Margin of PBH (18.09%) is better than 90.00% of its industry peers.
- PBH's Profit Margin has improved in the last couple of years.
- PBH has a Operating Margin of 31.00%. This is amongst the best in the industry. PBH outperforms 94.21% of its industry peers.
- In the last couple of years the Operating Margin of PBH has remained more or less at the same level.
- PBH's Gross Margin of 56.10% is fine compared to the rest of the industry. PBH outperforms 67.89% of its industry peers.
- In the last couple of years the Gross Margin of PBH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31% | ||
| PM (TTM) | 18.09% | ||
| GM | 56.1% |
OM growth 3Y0.37%
OM growth 5Y-0.32%
PM growth 3Y-0.06%
PM growth 5Y5%
GM growth 3Y-0.79%
GM growth 5Y-0.88%
2. Health
2.1 Basic Checks
- PBH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for PBH has been reduced compared to 1 year ago.
- PBH has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, PBH has an improved debt to assets ratio.
2.2 Solvency
- PBH has an Altman-Z score of 2.62. This is not the best score and indicates that PBH is in the grey zone with still only limited risk for bankruptcy at the moment.
- PBH's Altman-Z score of 2.62 is fine compared to the rest of the industry. PBH outperforms 64.21% of its industry peers.
- The Debt to FCF ratio of PBH is 3.97, which is a good value as it means it would take PBH, 3.97 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of PBH (3.97) is better than 86.32% of its industry peers.
- PBH has a Debt/Equity ratio of 0.55. This is a neutral value indicating PBH is somewhat dependend on debt financing.
- The Debt to Equity ratio of PBH (0.55) is worse than 66.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 3.97 | ||
| Altman-Z | 2.62 |
ROIC/WACC0.89
WACC8.84%
2.3 Liquidity
- A Current Ratio of 3.70 indicates that PBH has no problem at all paying its short term obligations.
- PBH has a Current ratio of 3.70. This is comparable to the rest of the industry: PBH outperforms 57.37% of its industry peers.
- A Quick Ratio of 2.51 indicates that PBH has no problem at all paying its short term obligations.
- PBH's Quick ratio of 2.51 is in line compared to the rest of the industry. PBH outperforms 52.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.7 | ||
| Quick Ratio | 2.51 |
3. Growth
3.1 Past
- PBH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.15%, which is quite good.
- The Earnings Per Share has been growing by 8.88% on average over the past years. This is quite good.
- The Revenue has decreased by -0.02% in the past year.
- Measured over the past years, PBH shows a small growth in Revenue. The Revenue has been growing by 3.39% on average per year.
EPS 1Y (TTM)13.15%
EPS 3Y3.72%
EPS 5Y8.88%
EPS Q2Q%-1.83%
Revenue 1Y (TTM)-0.02%
Revenue growth 3Y1.54%
Revenue growth 5Y3.39%
Sales Q2Q%-3.41%
3.2 Future
- Based on estimates for the next years, PBH will show a small growth in Earnings Per Share. The EPS will grow by 4.13% on average per year.
- Based on estimates for the next years, PBH will show a small growth in Revenue. The Revenue will grow by 1.15% on average per year.
EPS Next Y1.64%
EPS Next 2Y3.96%
EPS Next 3Y3.41%
EPS Next 5Y4.13%
Revenue Next Year-2.01%
Revenue Next 2Y0.22%
Revenue Next 3Y0.49%
Revenue Next 5Y1.15%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 14.41, the valuation of PBH can be described as correct.
- Based on the Price/Earnings ratio, PBH is valued cheaper than 86.84% of the companies in the same industry.
- When comparing the Price/Earnings ratio of PBH to the average of the S&P500 Index (27.21), we can say PBH is valued slightly cheaper.
- PBH is valuated correctly with a Price/Forward Earnings ratio of 13.42.
- Based on the Price/Forward Earnings ratio, PBH is valued cheaply inside the industry as 84.74% of the companies are valued more expensively.
- PBH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 25.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.41 | ||
| Fwd PE | 13.42 |
4.2 Price Multiples
- PBH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PBH is cheaper than 87.37% of the companies in the same industry.
- 88.95% of the companies in the same industry are more expensive than PBH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.37 | ||
| EV/EBITDA | 10.86 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PBH does not grow enough to justify the current Price/Earnings ratio.
- PBH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)8.78
PEG (5Y)1.62
EPS Next 2Y3.96%
EPS Next 3Y3.41%
5. Dividend
5.1 Amount
- PBH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PRESTIGE CONSUMER HEALTHCARE / PBH FAQ
What is the ChartMill fundamental rating of PRESTIGE CONSUMER HEALTHCARE (PBH) stock?
ChartMill assigns a fundamental rating of 6 / 10 to PBH.
Can you provide the valuation status for PRESTIGE CONSUMER HEALTHCARE?
ChartMill assigns a valuation rating of 6 / 10 to PRESTIGE CONSUMER HEALTHCARE (PBH). This can be considered as Fairly Valued.
What is the profitability of PBH stock?
PRESTIGE CONSUMER HEALTHCARE (PBH) has a profitability rating of 7 / 10.
What is the expected EPS growth for PRESTIGE CONSUMER HEALTHCARE (PBH) stock?
The Earnings per Share (EPS) of PRESTIGE CONSUMER HEALTHCARE (PBH) is expected to grow by 1.64% in the next year.